Skip to main content

Table 1 Clinical and pathological characteristics of the patients

From: Comparative study of endometrioid borderline ovarian tumor with and without endometriosis

Characteristics EAEBOT
(n = 19)
Non-EAEBOT
(n = 33)
P
Age(years)(mean ± SD) 39.9 ± 7.5 43.1 ± 13.3 0.280
Age ≥ 50 years 1(5.3%) 10(30.3%) 0.040
Nulliparous 9(47.4%) 15(45.5%) 0.894
Gravidity number > 2 4(21.1%) 11(33.3%) 0.405
Symptom
 Pelvic mass 19(100.0%) 28(84.8%) 0.145
 Vaginal bleeding 2(10.5%) 7(21.2%) 0.458
 Pain 1(5.3%) 5(15.2%) 0.397
 Torsion 0(0.0%) 2(6.1%) 0.527
 Distension 1(5.3%) 0(0.0%) 0.365
Menopause 0(0.0%) 12(36.4%) 0.002
CA125 > 35 U/ml 15(78.9%) 18(54.5%) 0.091
CA125 ≥ 140 U/ml 7(36.8%) 8(24.2%) 0.376
Maximal tumor diameter ≥ 10 cm 3(15.8%) 7(21.2%) 1.000
Cyst rupture 14(73.7%) 24(72.7%) 1.000
FIGO stage 1.000
 I 18(94.7%) 31(93.9%)
 II,III,IV 1(5.3%) 2(6.1%)
Tumor side 0.145
 Unilateral 19(100.0%) 28(84.8%)
 Bilateral 0(0.0%) 5(15.2%)
Endometrial pathology
 Endometrial cancer 5(26.3%) 6(18.2%) 0.503
 EIN 2(10.5%) 6(18.2%) 0.694
  1. EAEBOT endometriosis-associated endometrioid borderline ovarian tumor,
  2. EIN endometrial intraepithelial neoplasia